Skip to main content
Equibles

Avani Kanubaddi

Enveric Biosciences, Inc. (ENVB)

Equibles does not estimate personal net worth.

Get an email with a short summary when Enveric Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get ENVB alerts

About Avani Kanubaddi

Enveric Biosciences, Inc. reported in an 8-K filed May 24, 2023 that Avani Kanubaddi was terminated as President and Chief Operating Officer, effective June 17, 2023. The proxy statement of Enveric Biosciences, Inc. reports total compensation of $1,300,597 for Avani Kanubaddi in fiscal 2022, including a base salary of $335,833. Disclosed compensation is on record for 2 fiscal years. Enveric Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enveric Biosciences, Inc. includes David Johnson (CEO and Board Member), Dr. Joseph Tucker (CEO and Board Member), Joseph Tucker (CEO and Board Member) and 7 others.

“the Company terminated the employment contract of Mr. Kanubaddi without Cause (as defined in the Employment Agreement), the President and Chief Operating Officer of the Company, to be effective June 17, 2023 (the "Separation Date").”
Enveric Biosciences, Inc. Form 8-K, filed May 24, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Enveric Biosciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Enveric Biosciences, Inc. (ENVB) $335,833 $1,300,597
2021 Enveric Biosciences, Inc. (ENVB) $302,500 $4,236,593

Recent activity